Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Akeso Receives Breakthrough Therapy Designation for Ivonescimab in Advanced Biliary Tract Cancer
Friday, February 06, 2026Akeso has received a fifth Breakthrough Therapy Designation BTD from Chinas National Medical Products Administration NMPA for ivonescimab a bispecific antibody that targets PD and VEGF
Akeso Inc Receives NMPA Approval for Novel Bispecific Antibody AK Targeting Amyloid-Beta and BBB Receptor in China
Thursday, February 05, 2026Akeso Inc announced NMPA approval for its groundbreaking bispecific antibody AK targeting amyloidbeta and bloodbrain barrier receptors accelerating Alzheimers therapy innovation in Asia
Japan Leads Asia with 24 FDA Novel-Drug Approvals from 2015-2023: McKinsey Report
Wednesday, February 04, 2026Japan recorded the highest number of US FDA noveldrug approvals among Asian markets between and according to McKinsey Company
Zonsen PepLib Biotech Enters into Collaboration With Lilly For Peptide-based Drug Development
Wednesday, February 04, 2026Zonsen PepLib Biotech has entered into a global research and development collaboration and licensing agreement with Eli Lilly and Company
Relay Therapeutics’ Zovegalisib Receives Breakthrough Therapy Designation for Advanced Breast Cancer
Wednesday, February 04, 2026Relay Therapeutics has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to zovegalisib RLY
Japan Leads Asia with 24 FDA Novel-Drug Approvals from 2015-2023: McKinsey Report Highlights Regulatory Edge
Tuesday, February 03, 2026Japan recorded the highest number of US FDA noveldrug approvals among Asian markets between and driven by robust regulatory frameworks and a globally integrated biopharma ecosystem according to McKinsey
AstraZeneca Signs $18.5 Billion Weight-Loss Drug Deal with Chinese Firm CSPC
Monday, February 02, 2026AstraZeneca has licensed eight weightloss and diabetes drug programs from Chinas CSPC Pharmaceutical Group in a deal potentially worth billion
Asia Drives Pharmaceutical Growth in 2026 with China Leading Biopharma Innovation and Production Surge
Friday, January 30, 2026Asia particularly China India and Singapore is forecasted to drive pharmaceutical production growth in fueled by biopharma innovations RD investments and supply chain diversification
Recordati Enters into Collaboration with Moderna to Advance mRNA Therapy for Propionic Acidemia
Friday, January 30, 2026Recordati has announced a strategic collaboration and licence agreement with Moderna to develop and commercialise mRNA globally for the treatment of propionic acidemia a rare inherited metabolic disorder
Japan Approves 330 Billion JPY Support Package to Boost Drug Discovery and Biopharma Sector
Thursday, January 29, 2026Japans Cabinet Office approves billion JPY package targeting bioclusters rare disease trials cellgene therapy and biosimilars to strengthen its biopharma infrastructure
